BDR Buildcon Ltd. News and Updates

Keep track of all breaking news on BDR Buildcon Ltd. from all sources in a single place.

08 Mar 2025

Commission on 2009 BDR mutiny seeks deposed Sheikh Hasina's testimony

Business Standard

A commission instituted by Bangladesh's interim government led by Muhammad Yunus on Saturday asked deposed prime minister Sheikh Hasina and 14 others to submit their testimony as part of a re-investigation into the 2009 mutiny in the then Bangladesh Rifles (BDR) frontier force. The National Independent Investigation Commission on the 2009 BDR carnage has issued a public notice urging 15 individuals, including former Prime Minister Sheikh Hasina, to testify as part of its ongoing inquiry, the state-run BSS news agency said. The notice stated that legal measures would be taken against those who will fail to cooperate adding that the special notice was issued expecting to complete the process of recording testimonies of the 15 people, Bangladesh Sangbad Sangstha (BSS) said. The 15 people included the then army chief retired general Moeen U Ahmed, his grand successor general Aziz Ahmed and several other former military and police officers and politicians belonging to Hasina's ousted Awa

BDR Buildcon Ltd.

02 Jan 2024

BDR Pharma launches prostrate cancer drug in oral solution form

Business Line

A global first, BDR's oral solution drug for prostate cancer is expected to aid patient compliance, treatment flexibility

BDR Buildcon Ltd.

29 Sep 2023

BDR launches generic drug for fungal infections

Business Line

Zisavel is priced at7,992(forseven capsules), 1/3rdthe cost of present therapies available from the innovators, says BDR

BDR Buildcon Ltd.

03 Jan 2023

BDR looks to grow through risk-taking and collaborations

Business Line

Its generic apalutamide to treat prostrate cancer will be available by end of the week

BDR Pharmaceutical launches generic drug for treating prostate cancer in India

Moneycontrol | 03 Jan 2023 1 more

BDR Buildcon Ltd.

17 May 2022

BDR Pharma raises Rs 685-cr from PE investors led by Renuka Ramnath's Multiples

Business Line

Deal puts critical care drug maker's valuation at around $1 billion

PE firm Multiples picks up 9.3% stake in BDR Pharma for Rs 685 cr

Business Standard | 17 May 2022

BDR Buildcon Ltd.

18 Apr 2022

CCI clears investments in BDR Pharma

livemint

The competition regulator said the minority investment in the company was made by seven investors including two individuals

CCI approves deal to acquire minority stake in BDR Pharmaceuticals

Business Standard | 18 Apr 2022

BDR Buildcon Ltd.

28 Feb 2022

BDR Pharma introduces prostate cancer drug with enhanced strength

Business Standard

The company has introduced the medication, under the brand name BDENZA 160mg, at Rs 6,300 for a strip of seven tablets

BDR Buildcon Ltd.

29 Dec 2021

Mankind, BDR Pharma join hands to launch anti Covid-19 pill Molulife

Business Standard

Mankind Pharma on Wednesday said it has joined hands with BDR Pharmaceuticals to launch oral anti COVID-19 pill Molulife (Molnupiravir) in the country. The tie-up is a licensing arrangement where production is by BDR Pharma and marketing, selling, promotion, distribution is by Mankind Pharma, the company said in a statement. On Tuesday, the Drugs Controller General of India (DCGI) granted permission for restricted use of antiviral medication Molnupiravir under emergency situation for treatment of COVID-19 in adult patients who have a high risk of progression of the disease. This launch further enhances the COVID-19 treatment portfolio in BDR's product basket with the addition of generic Molnupiravir. We are pleased to collaborate with Mankind Pharma to take one step forward in fighting the virus," BDR Pharma Director Business Development Raheel Shah stated. Mankind Pharma Senior President (Sales & Marketing) Sanjay Koul noted that a pill for COVID-19 is bound to go miles in...

Mankind, BDR Pharma join hands to launch anti Covid-19 pill Molulife

Business Line | 29 Dec 2021

BDR Buildcon Ltd.

24 Jun 2021

Mankind Pharma inks distribution pact with BDR Pharma for Covid drug

Business Standard

Delhi-based Mankind Pharma operates in 34 overseas destinations.

BDR Buildcon Ltd.

19 May 2021

BDR Pharma inks licensing pact with Eli Lilly for Covid-19 treatment drug

Business Standard

Drug firm BDR Pharma on Wednesday said it has inked a licensing pact with Eli Lilly and Company for the manufacturing and distribution of Baricitinib for the treatment of Covid-19 in India

BDR Pharmaceuticals inks licensing pact with Eli Lilly for Baricitinib

Business Line | 19 May 2021

No results found

Is BDR Buildcon Ltd. worth buying?